An acceptance and commitment therapy-based intervention for opioid use disorder risk in individuals with cancer: A treatment development study.

acceptance and commitment therapy cancer oncology, opioids psychosocial support substance use treatment development

Journal

Journal of contextual behavioral science
ISSN: 2212-1447
Titre abrégé: J Contextual Behav Sci
Pays: Netherlands
ID NLM: 101616494

Informations de publication

Date de publication:
Apr 2023
Historique:
pmc-release: 25 04 2024
medline: 19 6 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: ppublish

Résumé

This paper describes the iterative development of an evidence-based behavioral intervention for individuals with cancer at risk for opioid use disorder, using the National Institutes of Health Stage Model for Behavioral Intervention Development. Adult patients with cancer from an outpatient palliative care clinic at an academic cancer center, with moderate to high risk of opioid misuse, were enrolled in a treatment development study that aimed to increase psychological flexibility. In this intervention, psychological flexibility is the posited mechanism of change for reduction of opioid use disorder risk. Patients completed baseline (pre-intervention) assessments, a six-session behavioral intervention based in Acceptance and Commitment Therapy, post-intervention assessments, and a semi-structured exit interview. Ten patients with moderate to high risk of opioid misuse completed the intervention. Patients rated the intervention as highly acceptable and were generally highly satisfied. Patients reported finding the coping skills helpful (e.g., mindfulness, cognitive defusion) and reported a preference for more sessions. These treatment development efforts have implications for the development and design of acceptance- and mindfulness-based, targeted interventions for individuals with cancer, receiving palliative care and at risk for opioid use disorder. Specifically, this six-session behavioral intervention to increase psychological flexibility was acceptable to patients and ready to be studied in a pilot RCT.

Identifiants

pubmed: 37333769
doi: 10.1016/j.jcbs.2023.04.006
pmc: PMC10270682
mid: NIHMS1899219
doi:

Types de publication

Journal Article

Langues

eng

Pagination

226-234

Subventions

Organisme : NCI NIH HHS
ID : K08 CA259538
Pays : United States

Déclaration de conflit d'intérêts

Competing Interests. The authors have no competing interests to declare. Conflict of Interest Given her role as an Editorial Board Member, Dr. Kristy Dalrymple had no involvement in the peer review of this article and had no access to information regard its peer review. The other authors have no competing interests to declare.

Références

Behav Modif. 2014 Jul;38(4):516-48
pubmed: 24402463
J Clin Gastroenterol. 2003 Mar;36(3):242-52
pubmed: 12590237
BMC Public Health. 2009 Dec 05;9:450
pubmed: 19961618
Pain Med. 2005 Nov-Dec;6(6):432-42
pubmed: 16336480
J Psychosom Obstet Gynaecol. 2013 Jun;34(2):60-7
pubmed: 23646866
Am Psychol. 2014 Feb-Mar;69(2):178-87
pubmed: 24547803
J Clin Oncol. 2012 Apr 20;30(12):1310-5
pubmed: 22430269
J Palliat Med. 2015 Aug;18(8):703-6
pubmed: 25922879
Clin J Pain. 2019 Jan;35(1):1-6
pubmed: 30222612
Pain Manag Nurs. 2018 Apr;19(2):115-124
pubmed: 29153294
JAMA Oncol. 2019 May 1;5(5):734-735
pubmed: 30920595
Internet Interv. 2016 Sep 04;6:16-21
pubmed: 30135810
J Natl Compr Canc Netw. 2013 Aug;11(8):1023-31
pubmed: 23946178
Drug Alcohol Rev. 2011 May;30(3):300-5
pubmed: 21545561
J Clin Oncol. 2014 Jun 1;32(16):1734-8
pubmed: 24799476
J Pain Symptom Manage. 2012 Dec;44(6):810-22
pubmed: 22771125
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Oncologist. 2012;17(10):1337-45
pubmed: 22688670
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Gen Hosp Psychiatry. 2019 Sep - Oct;60:128-136
pubmed: 31104826
Obes Rev. 2020 Jul;21(7):e13013
pubmed: 32181957
Behav Ther. 2011 Dec;42(4):676-88
pubmed: 22035996
Arch Gen Psychiatry. 1998 Nov;55(11):973-9
pubmed: 9819065
Depress Anxiety. 2016 May;33(5):370-83
pubmed: 27000501
Cancer. 2021 Sep 1;127(17):3137-3144
pubmed: 34043811
Int J Behav Med. 1997;4(1):92-100
pubmed: 16250744
Oncology (Williston Park). 1998 Apr;12(4):517-21, 524
pubmed: 9575525
Am J Psychiatry. 2018 Jan 1;175(1):47-53
pubmed: 28946762
Pain. 2011 Mar;152(3):533-542
pubmed: 21251756
J Pain Symptom Manage. 2000 Apr;19(4):274-86
pubmed: 10799794
J Consult Clin Psychol. 2002 Oct;70(5):1129-39
pubmed: 12362963
J Contextual Behav Sci. 2014 Jul;3(3):155-163
pubmed: 29057212
Clin J Pain. 2008 Jul-Aug;24(6):497-508
pubmed: 18574359
J Cogn Psychother. 2010 Jan 1;24(4):294-313
pubmed: 21234281
Curr Med Res Opin. 2017 Jun;33(6):1067-1076
pubmed: 28277862
J Opioid Manag. 2019 Jul/Aug;15(4):285-293
pubmed: 31637681
Am J Drug Alcohol Abuse. 2019;45(5):488-494
pubmed: 31021654
J Clin Psychol. 2014 Jul;70(7):644-57
pubmed: 24449031
J Pain Symptom Manage. 2019 Jan;57(1):20-27
pubmed: 30342243
Ann Palliat Med. 2019 Sep;8(4):490-497
pubmed: 31431028
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
Psychooncology. 2016 May;25(5):610-5
pubmed: 26130586
Behav Modif. 2007 Sep;31(5):543-68
pubmed: 17699117
Ther Clin Risk Manag. 2006 Dec;2(4):447-53
pubmed: 18360655
Behav Ther. 2013 Jun;44(2):180-98
pubmed: 23611068
J Pain. 2007 Jul;8(7):573-82
pubmed: 17499555
J Consult Clin Psychol. 2012 Feb;80(1):43-53
pubmed: 22040285
J Pain Symptom Manage. 2012 Feb;43(2):253-60
pubmed: 21680141
Clin Psychol Sci. 2014 Jan 1;2(1):22-34
pubmed: 25821658
Trials. 2016 Feb 11;17:77
pubmed: 26865162
Cogn Behav Ther. 2013;42(3):171-9
pubmed: 23419077
Life Sci. 2011 May 23;88(21-22):940-7
pubmed: 20934437
Anesth Analg. 2017 Nov;125(5):1741-1748
pubmed: 29049118
Addict Res Theory. 2008;16(2):149-165
pubmed: 27746709
Hum Psychopharmacol. 2012 Mar;27(2):156-66
pubmed: 22389080
Sleep Med Rev. 2016 Jun;27:20-8
pubmed: 26434673
Oncologist. 2015 Jun;20(6):692-7
pubmed: 25933929
Annu Rev Clin Psychol. 2019 May 7;15:503-528
pubmed: 30566371
Am J Hosp Palliat Care. 2015 Sep;32(6):654-9
pubmed: 24744398

Auteurs

Miryam Yusufov (M)

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School.

R Kathryn McHugh (RK)

McLean Hospital, Harvard Medical School.

Joseph A Greer (JA)

Massachussetts General Hospital, Harvard Medical School.

Kristy Dalrymple (K)

Warren Alpert Medical School of Brown University.

Timothy Sannes (T)

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School.

Ilana M Braun (IM)

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School.

James Tulsky (J)

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School.

William Pirl (W)

Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School.

Classifications MeSH